Skip to content

NEWBERY KIN&OSTEO THERAPY

Active Private limited companyfounded 2022active for 4 yearsRue du Centre 133, 5300 AndenneKBO/BCE: BE 0784.647.648

Lifetime

4 annual accounts with figures on one time axis
peak of €29,649 in 2024
€28,874▼ 2.6%
peak of €14,087 in 2024
€13,332▼ 5.4%
peak of €39,017 in 2025
€39,017▲ 0.9%
€84,030▲ 15.1%
Board1 name since 2022
1 director
Documentsfilings and deeds
04-06-202657 days before the deadline
2025micro format
Dividend €13,000Debts from €72,982 to €84,030

Key points

from the 2025 annual accounts

Equity

€39,017 ▲ 0.9%
38,6852024+13,332Profit-13,000Dividend39,0172025

NEWBERY KIN&OSTEO THERAPY paid out €13,000 in dividends. That is 98% of the 2025 profit.

Turnover

≈ €110,000 estimated

The micro format states no turnover.

Filings

4 annual accounts 1 late
AprilJune31 JulyOctober2022202320242025

The 2023 accounts came 26 days late. The other three were filed on time.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,332 companies had the same profile as NEWBERY KIN&OSTEO THERAPY has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,332 companies, not a prediction for NEWBERY KIN&OSTEO THERAPY. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 12-04-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0784647648
Incorporation Founding capital of €5,000, 100 shares · Founded by · appointed as director · published on 12-04-2022 · Gazette deed
First establishment Rue du Centre 133, Andenne
All 8 events

Official details

Source: KBO
Status
Active since 08-04-2022Normal situation
Activity
Sports and recreation educationNACE 85510and 1 other2 activities on the establishment unitFrom the articles, 13 activities
Establishment unit
2.331.706.2895300 Andenne, since 08-04-2022
Financial year end
31 December
Peppol
Reachable since 23-12-2025
Company details

Annual accounts 2025

€123,047▲ 10.2%
Filing
Filed on 04-06-2026, 57 days before the end of the filing period
Financials

Insights on NEWBERY KIN&OSTEO THERAPY

NEWBERY KIN&OSTEO THERAPY files the micro format. That format states no turnover. The gross margin rose from €17,220 in 2022 to €28,874 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NEWBERY KIN&OSTEO THERAPY

What is the company number of NEWBERY KIN&OSTEO THERAPY?
The company number of NEWBERY KIN&OSTEO THERAPY is 0784.647.648. The VAT number is the same number with BE in front: BE 0784.647.648.
Where is NEWBERY KIN&OSTEO THERAPY based?
The registered office is at Rue du Centre 133, 5300 Andenne.Company details
What does NEWBERY KIN&OSTEO THERAPY do?
According to the KBO register, the main activity of the establishment unit is sports and recreation education (NACE 85510). The KBO lists 1 more.
What is the legal form of NEWBERY KIN&OSTEO THERAPY?
NEWBERY KIN&OSTEO THERAPY is a private limited company (BV).
When was NEWBERY KIN&OSTEO THERAPY founded?
NEWBERY KIN&OSTEO THERAPY was founded on 08-04-2022.
Is NEWBERY KIN&OSTEO THERAPY still active?
Yes, NEWBERY KIN&OSTEO THERAPY is an active enterprise in the KBO register.
What is the turnover of NEWBERY KIN&OSTEO THERAPY?
The turnover in financial year 2025 is about €110,000. This figure is estimated from the gross margin of €28,874 and 3,267 comparable companies of the same size. It probably lies between €68,000 and €200,000. It is a rough estimate. In financial year 2024 turnover was €109,376.Financials
Is NEWBERY KIN&OSTEO THERAPY profitable?
In financial year 2025, NEWBERY KIN&OSTEO THERAPY made a profit of €13,332.
Where can I find the annual accounts of NEWBERY KIN&OSTEO THERAPY?
NEWBERY KIN&OSTEO THERAPY filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NEWBERY KIN&OSTEO THERAPY due?
NEWBERY KIN&OSTEO THERAPY must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.